|Dr. Roger J. Medel M.D.||1.67M||N/D||70|
|Mr. Joseph M. Calabro||920.35k||N/D||56|
|Ms. Vivian Lopez-Blanco||608.07k||N/D||59|
|Mr. John C. Pepia||N/D||N/D||54|
|Mr. Robert C. Bryant||N/D||N/D||N/D|
MEDNAX, Inc., together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. The company offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services. It also provides maternal-fetal care, including inpatient and office-based clinical care to expectant mothers and their unborn babies through maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians consisting of maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. The companys pediatric cardiology care services comprise inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through pediatric cardiologist subspecialists and other related clinical professionals. In addition, it provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, and pediatric surgeons, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of December 31, 2016, the companys network consisted of approximately 3,600 affiliated physicians. MEDNAX, Inc. was founded in 1979 and is headquartered in Sunrise, Florida.
La calificación ISS Governance QuickScore de MEDNAX, Inc. a partir del 15 de octubre de 2017 es 4. Las puntuaciones principales son Auditoría: 1; Junta: 4; Derechos del accionista: 4; Compensación: 7.